James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

3 Retailers That Should Just Call It Quits

Three retailers -- Best Buy (BBY), Sears Holdings (SHLD) and Abercrombie & Fitch (ANF) -- are past the point of no return.

Why GoPro Inc (GPRO), Perrigo Company plc Ordinary Shares (PRGO) and Xerox Corp (XRX) Are 3 of Today’s Worst Stocks

GoPro (GPRO), Perrigo Company (PRGO) and Xerox (XRX) couldn't win for losing on Monday. Here's the deal.

Valeant Pharmaceuticals Intl Inc (VRX): This Bet Looks Better

Valeant Pharmaceuticals (VRX) has a new CEO, Joe Papa, in place, but that's not the biggest reason you'd want to own Valeant stock from here.

Apple Inc. (AAPL): Q2 Earnings Preview

Apple's direction is far from clear right now, but Apple stock is almost certainly going to take investors for a ride on Wednesday.

Microsoft Corporation (MSFT): Don’t Sound the Alarm Just Yet

Microsoft (MSFT) is on the ropes following its fiscal Q3 report. For better or worse though, this has to happen to happen... maybe a few more times.